Search results
2024 NFL draft order: Updated picks for 2nd, 3rd rounds
Buccaneers Wire via Yahoo Sports· 24 hours agoArizona Cardinals (from TEN) 72. New York Jets 73. Dallas Cowboys (from MIN via DET) 74. Atlanta...
AbbVie Reports First-Quarter 2024 Financial Results
The Longview News-Journal· 1 day agoReports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable
Bucs’ full list of picks in the 2024 NFL draft
Buccaneers Wire· 5 days agoJacksonville Jaguars: WR Keon Coleman, Florida State Melina Myers-USA TODAY Sports Share Share this image gallery on Facebook on Twitter via text message...
Europe Roundup: Sterling falls against dollar, European shares rise, Gold retreats, Brent hovers...
EconoTimes· 5 days agoMarket Roundup Belgium Mar Consumer Confidence -6, -5 previous EU Government Budget to GDP -3.6%,...
America’s Roundup: Dollar firm as US rates take center stage, Wall Street stocks end higher, Gold...
EconoTimes· 5 days agoMarket Roundup Canada Mar IPPI (MoM) 0.8% ,0.8% forecast, 0.7% previous US Mar Chicago Fed National...
USD/INR loses traction ahead of Indian and US PMI data
The Forex Market· 5 days agoThe Indian Rupee (INR) gains ground on Tuesday, backed by likely equity inflows and US Dollar (USD)...
Gold dips to $2,330 as tempered Middle East tensions weaken safe-haven demand
The Forex Market· 5 days agoGold price drops as investors see no immediate escalation in Israel-Iran tensions. Fizzling Fed rate...
Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for...
ABC 26 New Orleans· 3 days ago...a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer and immunological diseases, announced today that two abstracts featuring the latest data on sunvozertinib in non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR)...
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
FOX 59 Indianapolis· 2 days ago...Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented in an oral...
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual...
Morningstar· 4 days agoPaul Thorton, M.D., of Cook Children’s Medical Center in Fort Worth, Texas, will present the poster, which details findings from the Company...
